Amy M. Belton, Ph.D., has served as a Biomedical Life Scientist/Technical Coordinator supporting the Congressionally Directed Medical Research Program since 2014. In her role as a Biomedical Life Scientist, she conducts a comprehensive analysis of a broad spectrum of biomedical and health-related information and data in response to diverse customer-generated requirements. She also serves as a coordinator for scientific meetings and the evaluation of interdisciplinary scientific research programs. She is the D.C. Chapter Chair of Women in Bio (WIB). WIB is an organization of professional women from all career walks in the field of life sciences. They are all volunteers and share the goal of enabling and empowering women to reach the highest levels of leadership and—more importantly—to fulfill their own career aspirations.
Dr. Belton completed her undergraduate studies at Claflin University in 1998. She then went on to graduate school at Howard University, studying the role of the mitochondrial free radical scavenger Manganese Superoxide Dismutase (MnSOD) in eukaryotic aging using the Drosophila melanogaster model system. After Dr. Belton graduated from Howard, she changed her focus to cancer research.
In 2007, she accepted a position at the Johns Hopkins University School of Medicine where she studied the oncogene High mobility Group A1 in various types of cancers. While she was a Postdoctoral Fellow and later a Research Associate, she was awarded a Maryland Stem Cell Research Fund Postdoctoral Award, Maryland Stem Cell Research Fund Exploratory Award (MSCRF), Alex’s Lemonade Stand Fund Young Investigator Award, American Association for Cancer Research Minorities in Cancer Research Award (AACR-MICR), and American Association for Cancer Research Women in Cancer Research Award (AACR-WICR).
During her career Dr. Belton has published 15 manuscripts in the fields of aging and cancer research. Since 2012, she has contributed to blogs and published articles related to the development and commercialization of biotherapeutics.